Loading…
Fulcrum Therapeutics, Inc. is projected to rise to $3.82 by 2027, a +7% move from its current price of $3.58. FULC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $3.49 | $3.58 | $3.68 | +0.03% |
| Aug 4 | $3.45 | $3.58 | $3.72 | +0.06% |
| Aug 5 | $3.43 | $3.58 | $3.75 | +0.09% |
| Aug 6 | $3.40 | $3.58 | $3.78 | +0.12% |
| Aug 7 | $3.38 | $3.59 | $3.80 | +0.15% |
| Aug 8 | $3.37 | $3.59 | $3.82 | +0.18% |
| Aug 9 | $3.35 | $3.59 | $3.84 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.35 | $3.59 | $3.84 | +0.21% |
| Week 2 | $3.26 | $3.60 | $3.96 | +0.43% |
| Week 3 | $3.20 | $3.60 | $4.06 | +0.64% |
| Week 4 | $3.15 | $3.61 | $4.14 | +0.86% |
| Week 5 | $3.10 | $3.62 | $4.22 | +1.07% |
| Week 6 | $3.06 | $3.63 | $4.29 | +1.29% |
| Week 7 | $3.03 | $3.63 | $4.36 | +1.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined diseases in the United States.
Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers programs for the treatment of diamond-blackfan anemia, Bone Marrow Failure Syndromes, novel fetal hemoglobin inducers, fibrotic disorders.
Fulcrum Therapeutics was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. It has a license agreement with CAMP4 which includes certain small molecule compounds, composition of matter and method of use patent rights, and know-how to research, develop, manufacture, use, and commercialize.
Fulcrum Therapeutics, Inc. (FULC) operates in the Healthcare sector. The stock’s current price is $3.76 and its market cap is $250.54M, with a rank of 3554.
The asset’s price context is mixed in the near term, with moving averages at $4.46 (SMA50) and $8.12 (SMA200), suggesting potential headwinds to the upside.
The 30-day range spans from $3.12 to $4.53, and the stock shows a neutral technical stance with RSI14 at 50, and support at $3.45 and resistance at $3.85. The annualized volatility is 50.
A major floor 12.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.2% away) — a key level to hold.
The nearest ceiling, 7.5% above — a clean break opens room to run.
A major ceiling 131.6% above — clearing it would confirm fresh momentum.
Key FULC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of FULC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.67 | Sell | $3.66 | Sell |
| MA 10 | $3.68 | Sell | $3.67 | Sell |
| MA 20 | $3.65 | Sell | $3.71 | Sell |
| MA 50 | $4.10 | Sell | $4.33 | Sell |
| MA 100 | $5.73 | Sell | $5.50 | Sell |
| MA 200 | $7.95 | Sell | $6.56 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.85 | Neutral |
| Stoch RSI (14) | 49.25 | Neutral |
| CCI (20) | -62.22 | Neutral |
| Williams %R (14) | -69.23 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | 0.56 | Buy |
| Bollinger %B (20,2) | 0.29 | Neutral |
| Stochastic %K (14) | 30.77 | Neutral |
| TRIX (15) | -0.55 | Sell |
| Awesome (5,34) | 0.02 | Buy |
| Ultimate (7,14,28) | 42.60 | Neutral |
| Momentum (10) | -0.07 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 3.64 | Sell |
| ADX (14) | 20.07 | Sell |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 50, and moving averages bidding at $4.46 (SMA50) and $8.12 (SMA200).
Near-term support sits at $3.45 and resistance at $3.85, with a 30-day range of $3.12 to $4.53.
The stock shows an annualized volatility of 50.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.14 | $3.58 | $4.63 | 0% | Neutral | |
| $3.06 | $3.82 | $5.03 | +7% | Neutral | |
| $3.89 | $4.99 | $6.82 | +39% | Bullish | |
| $4.44 | $5.83 | $8.18 | +63% | Bullish | |
| $4.69 | $6.26 | $9.01 | +75% | Bullish | |
| $5.10 | $6.94 | $10.18 | +94% | Bullish | |
| $4.99 | $6.90 | $10.32 | +93% | Bullish | |
| $5.30 | $7.44 | $11.32 | +108% | Bullish | |
| $5.80 | $8.26 | $12.75 | +131% | Bullish | |
| $6.42 | $9.27 | $14.52 | +159% | Bullish | |
| $8.23 | $12.65 | $21.04 | +253% | Bullish | |
| $16.20 | $27.76 | $50.35 | +675% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.14 | $3.58 | $4.35 | +0.00% |
| September 2026 | $3.04 | $3.59 | $4.36 | +0.39% |
| October 2026 | $3.10 | $3.68 | $4.51 | +2.42% |
| November 2026 | $3.16 | $3.78 | $4.68 | +2.75% |
| December 2026 | $3.09 | $3.72 | $4.63 | -1.73% |
Click any year to see its month-by-month FULC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, FULC could reach as high as $4.63, with a base case around $3.58 and support toward $3.14 — roughly 0% from $3.58. A consolidation phase looks the most probable path here.
Expect FULC to range from $3.06 to $5.03 through 2027. The $3.82 average target implies a +7% move from current prices. That is up +7% on the projected 2026 average. Price action looks broadly range-bound.
The FULC price prediction for 2028 points to an average of $4.99 (low $3.89, high $6.82) — a potential gain of +39% on today's $3.58. Buyers look set to stay in control over this stretch.
In 2029, FULC is projected to trade between $4.44 and $8.18, averaging $5.83 — a potential gain of +63% from today's $3.58. That is up +17% on the projected 2028 average. Momentum favours further upside here.
Fulcrum Therapeutics, Inc.'s 2030 outlook centres on $6.26, within a $4.69 to $9.01 range. That is up +8% on the projected 2029 average. That marks a +75% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, FULC could reach as high as $10.18, with a base case around $6.94 and support toward $5.10 — roughly +94% from $3.58. Momentum favours further upside here.
Expect FULC to range from $4.99 to $10.32 through 2032. The $6.90 average target implies a +93% move from current prices. That is -1% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
The FULC price prediction for 2033 points to an average of $7.44 (low $5.30, high $11.32) — a potential gain of +108% on today's $3.58. Momentum favours further upside here.
In 2034, FULC is projected to trade between $5.80 and $12.75, averaging $8.26 — a potential gain of +131% from today's $3.58. That is up +11% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Fulcrum Therapeutics, Inc.'s 2035 outlook centres on $9.27, within a $6.42 to $14.52 range. That is up +12% on the projected 2034 average. That marks a +159% change versus current levels. Momentum favours further upside here.
By 2040, FULC could reach as high as $21.04, with a base case around $12.65 and support toward $8.23 — roughly +253% from $3.58. Buyers look set to stay in control over this stretch.
Expect FULC to range from $16.20 to $50.35 through 2050. The $27.76 average target implies a +675% move from current prices. That is up +119% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in FULC today (≈ 279.329609 FULC) could be worth
$7,753.11
+$6,753.11 (+675%) by 2050 · US Dollar
Based on the average projected FULC price of $27.76 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in FULCwould be worth at today's price.
$1,000 invested in FULC on Jul 31, 2025 (≈ 148.58841 FULC) would be worth
$531.95
-$468.05 (-46.8%) today · 0.53× · US Dollar
Based on a FULC entry price of $6.73 vs. today's $3.58.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.72 | $962.37 | -3.8% |
| 1 month ago | $3.64 | $983.52 | -1.6% |
| 3 months ago | $7.36 | $486.41 | -51.4% |
| 6 months ago | $10.72 | $333.96 | -66.6% |
| 1 year ago | $6.73 | $531.95 | -46.8% |
| All time (5.0y) ago | $7.28 | $491.76 | -50.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our FULC forecast.
Our base-case forecast reaches $7.20 around 2033.
Implied market cap at $7.20: $549.34M
The multi-year forecast shows a bullish trajectory with rising average prices and growing ROI across the horizon.
In 2026, min $3.14, avg $3.76, max $4.84, roiPct 0, sentiment NEUTRAL.
In 2027, min $3.17, avg $3.99, max $5.32, roiPct 6.2, sentiment NEUTRAL.
In 2028, min $4.04, avg $5.24, max $7.26, roiPct 39.4, sentiment BULLISH.
In 2029, min $4.56, avg $6.06, max $8.65, roiPct 61.2, sentiment BULLISH.
In 2030, min $4.82, avg $6.54, max $9.58, roiPct 74, sentiment BULLISH.
In 2031, min $5.22, avg $7.23, max $10.81, roiPct 92.2, sentiment BULLISH.
In 2032, min $5.01, avg $7.06, max $10.77, roiPct 87.7, sentiment BULLISH.
In 2033, min $5.34, avg $7.66, max $11.89, roiPct 103.6, sentiment BULLISH.
In 2034, min $5.80, avg $8.45, max $13.34, roiPct 124.7, sentiment BULLISH.
In 2035, min $6.38, avg $9.43, max $15.12, roiPct 150.9, sentiment BULLISH.
In 2040, min $8.09, avg $12.84, max $21.92, roiPct 241.4, sentiment BULLISH.
In 2050, min $15.62, avg $27.99, max $52.42, roiPct 644.4, sentiment BULLISH.
Tap a question to reveal the answer.
2026 avg $3.76, min $3.14, max $4.84, roiPct 0, sentiment NEUTRAL; 2030 avg $6.54, min $4.82, max $9.58, roiPct 74, sentiment BULLISH.
Forecasts show a bullish trajectory from 2028 onward, with 2028 avg $5.24 and 2030 avg $6.54, both higher than the 2026 avg of $3.76; 2050 is forecast at an avg of $27.99 with roiPct 644.4. The current price is $3.76, and early years show NEUTRAL sentiment, so outcomes depend on future developments.
Yes. The forecast shows 2031 max $10.81, 2032 max $10.77, and 2033 max $11.89, indicating potential to exceed $10 in those years.
Current price is $3.76. The 2026 avg is also $3.76 with roiPct 0, indicating a flat near-term outlook before higher forecasts in later years.
2050 min $15.62, avg $27.99, max $52.42, roiPct 644.4, sentiment BULLISH.
Fulcrum Therapeutics, Inc. Community Discussion
0Share your Fulcrum Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.